Tag:
FDA expert panels
Latest Headlines
Latest Headlines
FDA notes concerns about Vivus diet pill safety ahead of panel
U.S. regulators have cited concerns about the safety of Vivus’ ( $VVUS ) experimental diet pill Qnexa in review documents as the California drug developer pursues the first FDA approval of a...
Eisai loses panel vote on new Dacogen use
A federal advisory panel voted down Eisai 's attempt to gain an approval for Dacogen as a treatment for acute myeloid leukemia. The pharma company has been trying to gain an OK to use the drug for
FDA commish counters industry critics on expert conflict rules
There's been an ongoing debate in biopharma circles over the impact a shortage of drug experts is having on the FDA's panel review process. But anyone looking for the agency to welcome changes in the
